Want to track ABT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 12 days
Summary
ABT trading today lower at €3.2, a decrease of 0.78% from yesterday's close, completing a monthly decrease of -3.32% or €0.11. Over the past 12 months, ABT stock lost -25.06%.
ABT pays dividends to its shareholders, with the most recent payment made on May 15, 2025. The next announced payment will be in In 1 month on Aug 15, 2025 for a total of €0.59.
The last earnings report, released on Apr 15, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Jul 16, 2025.
Abitare In S.p.A. has completed 8 stock splits, with the recent split occurring on Jan 02, 2013.
The company's stock is traded on 16 different exchanges and in various currencies, with the primary listing on NYSE (USD).
ABT Chart
Loading, please wait...
Abbott (ABT) Stock Drops Despite Market Gains: Important Facts to Note
In the closing of the recent trading day, Abbott (ABT) stood at $134.11, denoting a -1.58% move from the preceding trading day.
Zacks | 1 day ago
Abbott (ABT) Upgraded to Buy: Here's What You Should Know
Abbott (ABT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks | 1 day ago
Abbott Sees Upside on Diagnostics Growth, FreeStyle Libre Expansion
ABT stock surges 21.7% year to date on CGM sales growth and robust diagnostics demand, even as FX and macro risks weigh on forecasts.
Zacks | 1 day ago
Abitare In S.p.A. Dividends
 ABT In 1 weeks Announced | Quarterly | $0.59 Per Share |
| ABT 2 months ago Paid | Quarterly | $0.59 Per Share |
| ABT 5 months ago Paid | Quarterly | $0.59 Per Share |
| ABT 8 months ago Paid | Quarterly | $0.55 Per Share |
| ABT 11 months ago Paid | Quarterly | $0.55 Per Share |
Abitare In S.p.A. Earnings
| 17 Jul 2025 (In 1 week) Date | | 1.25 Cons. EPS | - EPS |
| 16 Jul 2025 (In 1 week) Date | | 1.25 Cons. EPS | - EPS |
| 15 Apr 2025 Date | | - Cons. EPS | - EPS |
| 22 Jan 2025 Date | | 1.34 Cons. EPS | 1.34 EPS |
| 16 Oct 2024 Date | | 1.2 Cons. EPS | 1.21 EPS |
| ABT In 1 weeks Announced | Quarterly | $0.59 Per Share |
| ABT 2 months ago Paid | Quarterly | $0.59 Per Share |
| ABT 5 months ago Paid | Quarterly | $0.59 Per Share |
| ABT 8 months ago Paid | Quarterly | $0.55 Per Share |
| ABT 11 months ago Paid | Quarterly | $0.55 Per Share |
| 17 Jul 2025 (In 1 week) Date | | 1.25 Cons. EPS | - EPS |
| 16 Jul 2025 (In 1 week) Date | | 1.25 Cons. EPS | - EPS |
| 15 Apr 2025 Date | | - Cons. EPS | - EPS |
| 22 Jan 2025 Date | | 1.34 Cons. EPS | 1.34 EPS |
| 16 Oct 2024 Date | | 1.2 Cons. EPS | 1.21 EPS |
Abitare In S.p.A. (ABT) FAQ
What is the stock price today?
The current price is €3.20.
On which exchange is it traded?
Abitare In S.p.A. is listed on NYSE.
What is its stock symbol?
The ticker symbol is ABT.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 2.2%.
What is its market cap?
As of today, no market cap data is available.
What is the earnings per share?
The EPS is 1.25.
When is the next earnings date?
The next earnings report will release on Jul 16, 2025.
Has Abitare In S.p.A. ever had a stock split?
Abitare In S.p.A. had 8 splits and the recent split was on Jan 02, 2013.
Abitare In S.p.A. Profile
| Medical - Devices Industry | Healthcare Sector | Robert B. Ford CEO | XMIL Exchange | US0028241000 ISIN |
| US Country | 114,000 Employees | 15 Jul 2025 Last Dividend | 2 Jan 2013 Last Split | 13 Jan 1978 IPO Date |
Overview
Abbott Laboratories is a global healthcare company that engages in the discovery, development, manufacturing, and sale of a wide range of health care products. With its foundation laid in 1888, and headquartered in North Chicago, Illinois, the company has established a significant presence worldwide. Abbott operates across four main sectors: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices, catering to a diverse range of healthcare needs from generic pharmaceuticals to advanced medical devices.
Products and Services
Abbott Laboratories offers a comprehensive portfolio of products and services across various healthcare domains:
- Generic Pharmaceuticals: Includes treatments for pancreatic exocrine insufficiency, irritable bowel syndrome, biliary spasm, intrahepatic cholestasis, depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease, vestibular vertigo, pain, fever, inflammation, migraine, anti-infective clarithromycin, influenza vaccine, and colon rhythm regulation products.
- Diagnostic Products: Offers laboratory and transfusion medicine systems in areas such as immunoassay, clinical chemistry, hematology, and transfusion. Includes molecular diagnostics for DNA and RNA processing and detection of infectious agents, point-of-care systems, blood gas testing cartridges, rapid diagnostics, molecular point-of-care testing for several diseases, cardiometabolic tests, drug and alcohol tests, remote patient monitoring, consumer self-tests, and laboratory automation and informatics solutions.
- Nutritional Products: Provides nutritional products for both pediatric and adult use, catering to the specific dietary needs of different age groups and health conditions.
- Medical Devices: Offers a wide array of devices for the treatment of cardiovascular diseases, including rhythm management, electrophysiology, heart failure, vascular, and structural heart devices. Additionally, the company develops diabetes care products such as blood glucose monitoring systems, along with neuromodulation devices for managing chronic pain and movement disorders.
Contact Information
Address: 100 Abbott Park Road
Phone: 224 667 6100
Website: https://www.abbott.com
2025 © Marketlog. All Rights Reserved.
